Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation

Kannel, 1982, Epidemiological features of atrial fibrillation, N Engl J Med, 306, 1018, 10.1056/NEJM198204293061703 Murgatroyd, 1993, Atrial arrhythmias, Lancet, 341, 1317, 10.1016/0140-6736(93)90824-Z Wijffels, 1995, Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats, Circulation, 92, 1954, 10.1161/01.CIR.92.7.1954 Morillo, 1995, Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation, Circulation, 91, 1588, 10.1161/01.CIR.91.5.1588 Tieleman, 1998, Early recurrences of atrial fibrillation after electrical cardioversion, J Am Coll Cardiol, 31, 167, 10.1016/S0735-1097(97)00455-5 Goette, 1996, Electrical remodeling in atrial fibrillation. Time course and mechanisms, Circulation, 94, 2968, 10.1161/01.CIR.94.11.2968 Everett, 2000, Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation, Circulation, 102, 1454, 10.1161/01.CIR.102.12.1454 Allessie, 2002, Electrical, contractile and structural remodeling during atrial fibrillation, Cardiovasc Res, 54, 230, 10.1016/S0008-6363(02)00258-4 Kostin, 2002, Structural correlate of atrial fibrillation in human patients, Cardiovasc Res, 54, 361, 10.1016/S0008-6363(02)00273-0 Lai, 1999, Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban, J Am Coll Cardiol, 33, 1231, 10.1016/S0735-1097(99)00008-X Brundel, 2001, Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation, Circulation, 103, 684, 10.1161/01.CIR.103.5.684 Brundel, 2002, Molecular mechanisms of remodeling in human atrial fibrillation, Cardiovasc Res, 54, 315, 10.1016/S0008-6363(02)00222-5 Dobrev, 2001, Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current I(K,ACh) in chronic human atrial fibrillation, Circulation, 104, 2551, 10.1161/hc4601.099466 Ausma, 2001, Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat, J Mol Cell Cardiol, 33, 2083, 10.1006/jmcc.2001.1472 Polontchouk, 2002, Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria, J Am Coll Cardiol, 39, 1709 van der Velden, 2000, Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat, Cardiovasc Res, 46, 476, 10.1016/S0008-6363(00)00026-2 Arndt, 2002, Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria, Circulation, 105, 720, 10.1161/hc0602.103639 Li, 1998, Differential expression of tissue inhibitors of metalloproteinases in the failing human heart, Circulation, 98, 1728, 10.1161/01.CIR.98.17.1728 Thomas, 1998, Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy, Circulation, 97, 1708, 10.1161/01.CIR.97.17.1708 Creemers, 2001, Matrix metalloproteinase inhibition after myocardial infarction, Circ Res, 89, 201, 10.1161/hh1501.094396 Spinale, 2002, Matrix metalloproteinases, Circ Res, 90, 520, 10.1161/01.RES.0000013290.12884.A3 Spinale, 2000, A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure, Circulation, 102, 1944, 10.1161/01.CIR.102.16.1944 Ducharme, 2000, Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction, J Clin Invest, 106, 55, 10.1172/JCI8768 Spinale, 2000, Myocardial matrix degradation and metalloproteinase activation in the failing heart, Cardiovasc Res, 46, 225, 10.1016/S0008-6363(99)00431-9 Romanic, 2002, Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9, Cardiovasc Res, 54, 549, 10.1016/S0008-6363(02)00254-7 Henny, 1991, Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization, Proc Natl Acad Sci U S A, 88, 8154, 10.1073/pnas.88.18.8154 Galis, 1994, Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques, J Clin Invest, 94, 2493, 10.1172/JCI117619 Bond, 2001, Inhibition of transcription factor NF-kappa B reduces matrix metalloproteinase-1, 3 and 9 production by vascular smooth muscle cells, Cardiovasc Res, 50, 556, 10.1016/S0008-6363(01)00220-6 Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmia, Circulation, 104, 2886, 10.1161/hc4901.101760 Veheule, 2003, Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial silatation due to mitral regurgitation, Circulation, 107, 2615, 10.1161/01.CIR.0000066915.15187.51 McQuibban, 2002, Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo, Blood, 100, 1160, 10.1182/blood.V100.4.1160.h81602001160_1160_1167 Bond, 1998, Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines, FEBS Lett, 435, 29, 10.1016/S0014-5793(98)01034-5 Bradham, 2002, Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure, Cardiovasc Res, 53, 822, 10.1016/S0008-6363(01)00503-X Goette, 2000, Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation, J Am Coll Cardiol, 35, 1669, 10.1016/S0735-1097(00)00611-2 Rouet-Benzineb, 2000, Angiotensin II induces nuclear factor–kappa-B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway, J Mol Cell Cardiol, 32, 1767, 10.1006/jmcc.2000.1211 Fraccarollo, 2002, Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure, Cardiovasc Res, 54, 85, 10.1016/S0008-6363(01)00553-3 Nakashima, 2000, Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation, Circulation, 101, 2612, 10.1161/01.CIR.101.22.2612